Literature DB >> 11172757

Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo.

K E Sabol1, J T Roach, S L Broom, C Ferreira, M M Preau.   

Abstract

Rats were treated with a high-dose methamphetamine (METH) regimen (40 mg/kg/injection, four times at 2-h intervals) or a saline regimen (four injections at 2-h intervals). Temperature related measures taken during the high-dose METH treatment were maximum core temperature and minimum chamber temperature. Fourteen rats (METH N=7; Saline N=7) were implanted with in-vivo dialysis probes 4-7 weeks post-regimen (average=6 weeks). The next day, they received a challenge dose of METH (4.0 mg/kg) and dopamine release was measured. Results showed a significant decrease in challenge-induced dopamine release in rats previously treated with the high-dose METH regimen. These findings demonstrate a functional deficit in the dopamine system 6 weeks after high-dose METH treatment. Temperature-related measures taken during the high-dose regimen were not correlated with METH-induced dopamine release 6 weeks later. An additional group of rats were sacrificed 6 weeks after the high-dose regimen (METH N=12; Saline N=10), and their brains was analyzed for dopamine and serotonin concentrations. Tissue concentrations of dopamine were significantly depleted in striatum and nucleus accumbens/olfactory tubercle, but not septum, hypothalamus, or ventral mid-brain 6 weeks after the high-dose regimen. Tissue concentrations of serotonin were also significantly depleted in striatum, nucleus accumbens/olfactory tubercle, hippocampus, somatosensory cortex, but not septum, hypothalamus or ventral mid-brain. Significant correlations between the temperature-related measures and post-mortem neurotransmitter tissue concentrations were region and transmitter dependent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172757     DOI: 10.1016/s0006-8993(00)03244-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.

Authors:  Kequan Fu; Huiyang Lin; Yoshiaki Miyamoto; Chunfu Wu; Jingyu Yang; Kyosuke Uno; Atsumi Nitta
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

2.  Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats.

Authors:  Cesar A Romero; Diego A Bustamante; Gerald Zapata-Torres; Michel Goiny; Bruce Cassels; Mario Herrera-Marschitz
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

Review 3.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

4.  Relationship between methamphetamine exposure and matrix metalloproteinase 9 expression.

Authors:  Yun Liu; Sheketta Brown; Jamaluddin Shaikh; James A Fishback; Rae R Matsumoto
Journal:  Neuroreport       Date:  2008-09-17       Impact factor: 1.837

5.  Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity.

Authors:  David M Thomas; Dina M Francescutti-Verbeem; Donald M Kuhn
Journal:  J Neurochem       Date:  2009-04-28       Impact factor: 5.372

6.  The effects of methamphetamine on core body temperature in the rat--part 1: chronic treatment and ambient temperature.

Authors:  Benita J Myles; Lee Ann Jarrett; Susan L Broom; H Anton Speaker; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-27       Impact factor: 4.530

7.  The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.

Authors:  Benita J Myles; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-26       Impact factor: 4.530

8.  Methamphetamine and core temperature in the rat: ambient temperature, dose, and the effect of a D2 receptor blocker.

Authors:  Karen E Sabol; Danielle M Yancey; H Anton Speaker; Scott L Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2013-06-04       Impact factor: 4.530

9.  Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.

Authors:  Steven Shoptaw; Keith G Heinzerling; Erin Rotheram-Fuller; Trevor Steward; Jason Wang; Aimee-Noelle Swanson; Richard De La Garza; Tom Newton; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2008-05-12       Impact factor: 4.492

10.  The Persistent Neurotoxic Effects of Methamphetamine on Dopaminergic and Serotonergic Markers in Male and Female Rats.

Authors:  Lisa M McFadden; Paula L Vieira-Brock
Journal:  Toxicol Open Access       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.